Get started
Author

Madalina Bolovan

Observed names: L.M. Bolovan, Lucica Madalina Bolovan, Lucica-Madalina BOLOVAN, M. Bolovan, Madalina Lucica Bolovan
Observed institution: Institutul Oncologic Bucuresti
ORCID: 0000-0003-4614-1290
Observed ORCID: 0000-0003-4614-1290
OpenAlex ID: A5090223249
Prognostic Value of Melanoma Inhibitory Activity Protein in Localized Cutaneous Malignant Melanoma
2014 · Angela Sandru, Eugenia Panaitescu, et al. · Journal of Skin Cancer · 30
PDF
Melanoma and immunotherapy bridge 2015: Naples, Italy. 1–5 December 2015
2016 · Vashisht G. Y. Nanda, Weiyi Peng, et al. · Journal of Translational Medicine · 23
PDF
Correlation Studies between S100 Protein Level and Soluble MIA or Tissue MelanA and gp100 (HMB45) Expression in Cutaneous Melanoma
2023 · Lucica Madalina Bolovan, Mihai Ceausu, et al. · Journal of Personalized Medicine · 18
PDF
Variation in Immune and Inflammatory Blood Markers in Advanced Melanoma Patients Treated with PD-1 Inhibitors: A Preliminary Exploratory Study
2025 · Lucica Madalina Bolovan, Marieta Elena Panait, et al. · Biomedicines · 4
PDF
Clinical value of Melanoma Inhibitory Activity in stratifying malignant melanoma patients
2015 · Angela Sandru, Silviu Voinea, et al. · Journal of Translational Medicine · 2
PDF
The Interplay Between High Cumulative Doses of Radioactive Iodine and Type 2 Diabetes Mellitus: A Complex Cardiovascular Challenge
2024 · Adina Elena Stanciu, Madalina Lucica Bolovan, et al. · International Journal of Molecular Sciences · 1
PDF
Modulation of the Therapeutic Resistance in SK-MEL-24 Human Melanoma Cells by Combined Treatments
2025 · Lucica Madalina Bolovan, Marieta Elena Panait, et al. · Applied Sciences
PDF
Insights into the association between radioactive iodine therapy and cardiovascular disease in differentiated thyroid cancer
2024 · A.E. Stanciu, M. Bolovan, et al. · Clinica Chimica Acta
37P Growth/differentiation factor-15 from biomarker to target in cancer
2022 · A.E. Stanciu, L.M. Bolovan, et al. · Annals of Oncology
PDF
1650P The interplay of peripheral circulating free DNA and platelet-to-lymphocyte ratio in patients with differentiated thyroid cancer with/without type 2 diabetes mellitus undergoing radioiodine therapy
2022 · A.E. Stanciu, L.M. Bolovan, et al. · Annals of Oncology
Prognostic value of peripheral blood lymphocyte subsets in patients with solid cancers: a retrospective study
2021 · ", Marieta-Elena PANAIT, et al. · Archives of the Balkan Medical Union
PDF
66P TGF-β1: A crucial mediator of radioiodine therapy-induced anti-tumor immunity
2021 · A.E. Stanciu, M. Bolovan, et al. · Annals of Oncology
PDF
39P TGF-β1 and TNF-α: Antagonistic cytokines controlling extracellular matrix remodeling after radioactive iodine therapy for papillary thyroid carcinoma
2020 · A.E. Stanciu, A.E. Hurduc, et al. · Annals of Oncology
Immunoassay techniques for specific skin cancer biomarkers
2019 · M. Bolovan, A. Busca, et al. · Journal of Biotechnology
PP-APR13-022 In vitro and in vivo effects induced by (68)Ga -NODAGA-c(RGDfK) and (68)Ga-DOTA-c(RGDfK) in murine malignant melanoma
2019 · M.E. Panait, I. Gruia, et al. · Journal of Biotechnology
Comparative molecular and genetic particularities in human and animals mammary cancers
2019 · A. Busca, M. Bolovan, et al. · Journal of Biotechnology
Identifying the melanoma patients with high risk for metastasis
2018 · Madalina Bolovan, Sabin Cinca, et al. · Journal of Biotechnology
Concomitant determination of MIA and S100 proteins as prognostic factors in cutaneous malignant melanoma
2017 · Madalina Bolovan, Silviu Voinea, et al. · Journal of Biotechnology
Melanoma Inhibitory Activity and regional lymph node status in malignant melanoma patients
2015 · Angela Sandru, Silviu Voinea, et al. · Journal of Translational Medicine
PDF
Simultaneous determination of two serum tumor markers in assessing malignant melanoma patients
2015 · Angela Sandru, Silviu Voinea, et al. · Journal of Translational Medicine
PDF
The Significance of Serum S100, Mia and Ldh in Cutaneous Malignant Melanoma
2011 · Angela Sandru, Silviu Cristian Voinea, et al.
Works count: 22
Citation count: 78
H-index: 4
I10-index: 3
Year
Topic
Type